Global Continuous Blood Glucose Monitoring market overview 2024, Forecast To 2033
14 Feb, 2024
The continuous blood glucose monitoring market has witnessed rapid growth, increasing from $8.09 billion in 2023 to $9.68 billion in 2024, with a compound annual growth rate (CAGR) of 19.7%. The growth in the historic period is attributed to the increase in diabetes prevalence, regulatory compliance, demand for remote monitoring, emerging markets, and a rise in healthcare spending. Looking ahead, the market is expected to see exponential growth, reaching $20.44 billion in 2028 at a CAGR of 20.5%. The anticipated growth in the forecast period can be attributed to the growing aging population, rising home healthcare, telehealth expansion, a rise in healthcare expenditure, and an increase in disposable income. Major trends expected in the forecast period include wearable integration, artificial intelligence and machine learning, advanced sensors and accuracy, and partnerships and collaboration.
Global Continuous Blood Glucose Monitoring Market Key Driver
The growth in the prevalence of diabetes is expected to fuel the continuous blood glucose monitoring market. The International Diabetes Federation estimates a global diabetic population increase to 643 million by 2030 and further to 783 million by 2045. With approximately 537 million adults living with diabetes in 2021, the rising prevalence of diabetes is expected to drive the continuous blood glucose monitoring market growth in 2023, 2024, and 2028.
Get A Free Sample Of The Global Continuous Blood Glucose Monitoring Market ReportGlobal Continuous Blood Glucose Monitoring Market Segments
The global continous blood glucose monitoring market covered in this report is segmented –
1) By Component: Insulin Pumps, Sensors, Transmitters, Receivers
2) By Application: Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, Critical Care Patients
3) By End User: Hospitals, Homecare Diagnostics, Other End Users
By Geography: The regions covered in the Continuous Blood Glucose Monitoring market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa.
North Americawas the largest region in the continuous blood glucose monitoring market in 2023. The regions covered in the continous blood glucose monitoring market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Major Continuous Blood Glucose Monitoring Industry Players
F. Hoffmann-La Roche Ltd., Lifescan Inc., Medtronic plc., Abbott Laboratories, GlySens Inc., Arkray, Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., Goldsite Diagnostics Inc., AgaMatrix Inc., B. Braun Melsungen AG, Ypsomed Holding AG, Terumo Corporation, Orsense Ltd., Dexcom Inc., A. Menarini Diagnostics, Echo Therapeutics Inc., Johnson & Johnson Services Inc., Ascensia Diabetes Care Holdings AG, Insulet Corporation, Medtrum Technologies Inc., Texas Instruments Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., One Drop Inc., DarioHealth Corp., MedAngel BV, GluSense Ltd., PKvitality, Nemotecnia S.A.
Get The Full Global Continuous Blood Glucose Monitoring Market Report
Continuous Blood Glucose Monitoring Market Overview
A continuous blood glucose monitoring device enables a person to better regulate glucose levels throughout the day and experience fewer low blood glucose situations.
Continuous Blood Glucose Monitoring Global Market Report 2023 provides data on the global continuous blood glucose monitoring market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The continuous blood glucose monitoring market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.